Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling

References

• BurkittDA sarcoma involving the jaws in African childrenBr J Surg19584619721822313628987
   PubMed Web of Science ®Google Scholar
• CrawfordDHBiology and disease associations of Epstein-Barr virusPhilos Trans R Soc Lond B Biol Sci2001356140846147311313005
   PubMed Web of Science ®Google Scholar
• Dalla-FaveraRBregniMEriksonJPattersonDGalloRCCroceCMHuman c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cellsProc Natl Acad Sci U S A19827924782478276961453
   PubMed Web of Science ®Google Scholar
• TaubRKirschIMortonCTranslocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cellsProc Natl Acad Sci U S A19827924783778416818551
   PubMed Web of Science ®Google Scholar
• MoormannAMSniderCJChelimoKThe company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphomaCurr Opin Infect Dis2011245435441
   PubMed Web of Science ®Google Scholar
• SpenderLCInmanGJInhibition of germinal centre apoptotic programmes by epstein-barr virusAdv Hematol2011201182952522110506
   PubMedGoogle Scholar
• ChangTCYuDLeeYSWidespread microRNA repression by Myc contributes to tumorigenesisNat Genet2008401435018066065
   PubMed Web of Science ®Google Scholar
• O’DonnellKAWentzelEAZellerKIDangCVMendellJTc-Myc-regulated microRNAs modulate E2F1 expressionNature2005435704383984315944709
   PubMed Web of Science ®Google Scholar
• BlackwellTKKretznerLBlackwoodEMEisenmanRNWeintraubHSequence-specific DNA binding by the c-Myc proteinScience1990250498411491151
   PubMed Web of Science ®Google Scholar
• BlackwellTKHuangJMaABinding of myc proteins to canonical and noncanonical DNA sequencesMol Cell Biol1993139521652248395000
   PubMed Web of Science ®Google Scholar
• LüscherBMAD1 and its life as a MYC antagonist: an updateEur J Cell Biol2012916–750651421917351
   PubMed Web of Science ®Google Scholar
• TaubRMouldingCBatteyJActivation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cellsCell19843623393486319017
   PubMed Web of Science ®Google Scholar
• ar-RushdiANishikuraKEriksonJWattRRoveraGCroceCMDifferential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphomaScience198322246223903936414084
   PubMed Web of Science ®Google Scholar
• HaydayACGilliesSDSaitoHActivation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locusNature198430759493343406420706
   PubMed Web of Science ®Google Scholar
• JohnstonLAProberDAEdgarBAEisenmanRNGallantPDrosophila myc regulates cellular growth during developmentCell199998677979010499795
   PubMed Web of Science ®Google Scholar
• GrewalSSLiLOrianAEisenmanRNEdgarBAMyc-dependent regulation of ribosomal RNA synthesis during Drosophila developmentNat Cell Biol20057329530215723055
   PubMed Web of Science ®Google Scholar
• BouchardCStellarPEilersMControl of cell proliferation by MycTrends Cell Biol1998852022069695840
   PubMed Web of Science ®Google Scholar
• ParkSSKimJSTessarolloLInsertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in miceCancer Res20056541306131515735016
   PubMed Web of Science ®Google Scholar
• YinXGiapCLazoJSProchownikEVLow molecular weight inhibitors of Myc-Max interaction and functionOncogene200322406151615913679853
   PubMed Web of Science ®Google Scholar
• Gomez-CuretIPerkinsRSBennettRFeidlerKLDunnSPKruegerLJc-Myc inhibition negatively impacts lymphoma growthJ Pediatr Surg2006411207211 discussion 207–21116410134
   PubMed Web of Science ®Google Scholar
• SampsonVBRongNHHanJMicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cellsCancer Res200767209762977017942906
   PubMed Web of Science ®Google Scholar
• SpenderLCInmanGJPhosphoinositide 3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt’s lymphoma cells to BH3 mimeticsMol Cancer Res201210334735922241218
   PubMed Web of Science ®Google Scholar
• SchuhmacherMStaegeMSPajicAControl of cell growth by c-Myc in the absence of cell divisionCurr Biol19999211255125810556095
   PubMed Web of Science ®Google Scholar
• SchlosserIHölzelMHoffmannRDissection of transcriptional programmes in response to serum and c-Myc in a human B-cell lineOncogene200524352052415516975
   PubMed Web of Science ®Google Scholar
• MarinkovicDMarinkovicTMahrBHessJWirthTReversible lymphomagenesis in conditionally c-MYC expressing miceInt J Cancer2004110333634215095297
   PubMed Web of Science ®Google Scholar
• SchuhmacherMKohlhuberFHölzelMThe transcriptional program of a human B cell line in response to MycNucleic Acids Res200129239740611139609
   PubMed Web of Science ®Google Scholar
• JiHWuGZhanXCell-type independent MYC target genes reveal a primordial signature involved in biomass accumulationPLoS One2011610e2605722039435
   PubMed Web of Science ®Google Scholar
• LinCYLovénJRahlPBTranscriptional amplification in tumor cells with elevated c-MycCell20121511566723021215
   PubMed Web of Science ®Google Scholar
• LiZVan CalcarSQuCCaveneeWKZhangMQRenBA global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cellsProc Natl Acad Sci U S A2003100148164816912808131
   PubMed Web of Science ®Google Scholar
• SeitzVButzhammerPHirschBDeep sequencing of MYC DNA-binding sites in Burkitt lymphomaPLoS One2011611e26837
   PubMed Web of Science ®Google Scholar
• FanJZellerKChenYCTime-dependent c-Myc transactomes mapped by Array-based nuclear run-on reveal transcriptional modules in human B cellsPLoS One201053e969120300622
   PubMed Web of Science ®Google Scholar
• LoveCSunZJimaDThe genetic landscape of mutations in Burkitt lymphomaNat Genet201244121321132523143597
   PubMed Web of Science ®Google Scholar
• HannSREisenmanRNProteins encoded by the human c-myc oncogene: differential expression in neoplastic cellsMol Cell Biol1984411248624976513926
   PubMed Web of Science ®Google Scholar
• SakamuroDPrendergastGCNew Myc-interacting proteins: a second Myc network emergesOncogene199918192942295410378691
   PubMed Web of Science ®Google Scholar
• KuttlerFAméPClarkHc-myc box II mutations in Burkitt’s lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuliOncogene200120426084609411593416
   PubMed Web of Science ®Google Scholar
• SearsRNuckollsFHauraETayaYTamaiKNevinsJRMultiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityGenes Dev200014192501251411018017
   PubMed Web of Science ®Google Scholar
• SalghettiSEKimSYTanseyWPDestruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize MycEMBO J19991837177269927431
   PubMed Web of Science ®Google Scholar
• GregoryMAHannSRc-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt’s lymphoma cellsMol Cell Biol20002072423243510713166
   PubMed Web of Science ®Google Scholar
• BahramFvon der LehrNCetinkayaCLarssonLGc-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnoverBlood20009562104211010706881
   PubMed Web of Science ®Google Scholar
• HoangATLutterbachBLewisBCA link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domainMol Cell Biol1995158403140427623799
   PubMed Web of Science ®Google Scholar
• BouchardCLeeSPaulus-HockVLoddenkemperCEilersMSchmittCAFoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfGenes Dev200721212775278717974917
   PubMed Web of Science ®Google Scholar
• EischenCMWeberJDRousselMFSherrCJClevelandJLDisruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesisGenes Dev199913202658266910541552
   PubMed Web of Science ®Google Scholar
• PostSMQuintás-CardamaATerzianTSmithCEischenCMLozanoGp53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesisOncogene20102991260126919935700
   PubMed Web of Science ®Google Scholar
• FarrellPJAllanGJShanahanFVousdenKHCrookTp53 is frequently mutated in Burkitt’s lymphoma cell linesEMBO J19911010287928871915267
   PubMed Web of Science ®Google Scholar
• VousdenKHCrookTFarrellPJBiological activities of p53 mutants in Burkitt’s lymphoma cellsJ Gen Virol199374Pt 58038108492087
   PubMed Web of Science ®Google Scholar
• LeventakiVRodicVTrippSRTP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of casesBr J Haematol2012158676377122845047
   PubMed Web of Science ®Google Scholar
• LindströmMSKlangbyUWimanKGp14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53Oncogene200120172171217711360201
   PubMed Web of Science ®Google Scholar
• PujalsARenoufBRobertAChelouahSHollvilleEWielsJTreatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosisCell Death Dis20112e18421796156
   PubMed Web of Science ®Google Scholar
• EgleAHarrisAWBouilletPCorySBim is a suppressor of Myc-induced mouse B cell leukemiaProc Natl Acad Sci U S A2004101166164616915079075
   PubMed Web of Science ®Google Scholar
• DangCVO’donnellKAJuopperiTThe great MYC escape in tumorigenesisCancer Cell20058317717816169462
   PubMed Web of Science ®Google Scholar
• HemannMTBricATeruya-FeldsteinJEvasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature2005436705280781116094360
   PubMed Web of Science ®Google Scholar
• EischenCMRousselMFKorsmeyerSJClevelandJLBax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesisMol Cell Biol200121227653766211604501
   PubMed Web of Science ®Google Scholar
• PaschosKSmithPAndertonEMiddeldorpJMWhiteREAlldayMJEpstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene BimPLoS Pathog200956e100049219557159
   PubMed Web of Science ®Google Scholar
• Richter-LarreaJARoblesEFFresquetVReversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphomaBlood2010116142531254220570860
   PubMed Web of Science ®Google Scholar
• ErlacherMLabiVManzlCPuma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis inductionJ Exp Med2006203132939295117178918
   PubMed Web of Science ®Google Scholar
• GarrisonSPJeffersJRYangCSelection against PUMA gene expression in Myc-driven B-cell lymphomagenesisMol Cell Biol200828175391540218573879
   PubMed Web of Science ®Google Scholar
• SpenderLCCarterMJO’BrienDITransforming growth factor-β directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomasJ Biol Chem201328875198520923243310
   PubMed Web of Science ®Google Scholar
• SpenderLCO’BrienDISimpsonDTGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XLCell Death Differ200916459360219136942
   PubMed Web of Science ®Google Scholar
• SanderSCaladoDPSrinivasanLSynergy between PI3K signaling and MYC in Burkitt lymphomagenesisCancer Cell201222216717922897848
   PubMed Web of Science ®Google Scholar
• RohnJLHueberAOMcCarthyNJThe opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosisOncogene19981722281128189879987
   PubMed Web of Science ®Google Scholar
• ZhaoJJGjoerupOVSubramanianRRHuman mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinaseCancer Cell20033548349512781366
   PubMed Web of Science ®Google Scholar
• KumarAMarquésMCarreraACPhosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entryMol Cell Biol200626239116912517015466
   PubMed Web of Science ®Google Scholar
• HanSSYunHSonDJNF-kappaB/STAT3/PI3K signaling crosstalk in iMyc E mu B lymphomaMol Cancer201099720433747
   PubMed Web of Science ®Google Scholar
• BouchardCMarquardtJBrásAMedemaRHEilersMMyc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteinsEMBO J200423142830284015241468
   PubMed Web of Science ®Google Scholar
• CurnockAPKnoxKALY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cellsCell Immunol1998187277879732695
   PubMed Web of Science ®Google Scholar
• BrennanPMehlAMJonesMRoweMPhosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cellsOncogene20022181263127111850846
   PubMed Web of Science ®Google Scholar
• PeledJUYuJJVenkateshJRequirement for cyclin D3 in germinal center formation and functionCell Res2010206631646
   PubMed Web of Science ®Google Scholar
• CatoMHChintalapatiSKYauIWOmoriSARickertRCCyclin D3 is selectively required for proliferative expansion of germinal center B cellsMol Cell Biol201131112713720956554
   PubMed Web of Science ®Google Scholar
• MøllerMBNielsenOPedersenNTCyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical featuresAm J Clin Pathol2001115340441211242797
   PubMed Web of Science ®Google Scholar
• SchmitzRYoungRMCeribelliMBurkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomicsNature2012490741811612022885699
   PubMed Web of Science ®Google Scholar
• GoldfarbANFloresJPLewandowskaKInvolvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switchingMol Immunol19963311–129479568960119
   PubMed Web of Science ®Google Scholar
• RichterJSchlesnerMHoffmannSICGC MMML-Seq ProjectRecurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencingNat Genet201244121316132023143595
   PubMed Web of Science ®Google Scholar
• SpenderLCLucchesiWBodelonGCell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cellsJ Gen Virol200687Pt 102859286716963743
   PubMed Web of Science ®Google Scholar
• SchildCWirthMReichertMSchmidRMSaurDSchneiderGPI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cellsMol Carcinog200948121149115819603422
   PubMed Web of Science ®Google Scholar
• van WeerenPCde BruynKMde Vries-SmitsAMvan LintJBurgeringBMEssential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKBJ Biol Chem19982732113150131569582355
   PubMed Web of Science ®Google Scholar
• AmenteSZhangJLavaderaMLLaniaLAvvedimentoEVMajelloBMyc and PI3K/AKT signaling cooperatively repress FOXO3a-dependent PUMA and GADD45a gene expressionNucleic Acids Res201139229498950721835778
   PubMed Web of Science ®Google Scholar
• AshcroftMLudwigRLWoodsDBPhosphorylation of HDM2 by AktOncogene200221131955196211960368
   PubMed Web of Science ®Google Scholar
• CardoneMHRoyNStennickeHRRegulation of cell death protease caspase-9 by phosphorylationScience19982825392131813219812896
   PubMed Web of Science ®Google Scholar
• DevlinJRHannanKMNgPYAKT signalling is required for ribosomal RNA synthesis and progression of Eμ-Myc B-cell lymphoma in vivoFEBS J Epub1192013
   Web of Science ®Google Scholar
• HsiehACCostaMZolloOGenetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4ECancer Cell201017324926120227039
   PubMed Web of Science ®Google Scholar
• DowlingRJTopisirovicIAlainTmTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPsScience201032859821172117620508131
   PubMed Web of Science ®Google Scholar
• FeldmanMEApselBUotilaAActive-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2PLoS Biol200972e3819209957
   PubMed Web of Science ®Google Scholar
• ThoreenCCSabatiniDMRapamycin inhibits mTORC1, but not completelyAutophagy20095572572619395872
   PubMed Web of Science ®Google Scholar
• ZhuJBlenisJYuanJActivation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1Proc Natl Acad Sci U S A2008105186584658918451027
   PubMed Web of Science ®Google Scholar
• LiSTakasuTPerlmanDMTranslation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c releaseJ Biol Chem200327853015302212441348
   PubMed Web of Science ®Google Scholar
• MillsJRHippoYRobertFmTORC1 promotes survival through translational control of Mcl-1Proc Natl Acad Sci U S A200810531108531085818664580
   PubMed Web of Science ®Google Scholar
• WallMPoortingaGStanleyKLThe mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescenceCancer Discov201331829523242809
   PubMed Web of Science ®Google Scholar
• GrespiFSoratroiCKrumschnabelGBH3-only protein Bmf mediates apoptosis upon inhibition of CAP-dependent protein synthesisCell Death Differ201017111672168320706276
   PubMed Web of Science ®Google Scholar
• ShorttJMartinBPNewboldACombined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomasBlood2013121152964297423403624
   PubMed Web of Science ®Google Scholar
• PourdehnadMTruittMLSiddiqiINDuckerGSShokatKMRuggeroDMyc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancersProc Natl Acad Sci U S A201311029119881199323803853
   PubMed Web of Science ®Google Scholar
• AlldayMJHow does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt’s lymphoma?Semin Cancer Biol200919636637619635566
   PubMed Web of Science ®Google Scholar
• SinclairAJPalmeroIPetersGFarrellPJEBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virusEMBO J19941314332133288045261
   PubMed Web of Science ®Google Scholar
• KaiserCLauxGEickDJochnerNBornkammGWKempkesBThe proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2J Virol19997354481448410196351
   PubMed Web of Science ®Google Scholar
• SpenderLCCornishGHRowlandBKempkesBFarrellPJDirect and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infectionJ Virol20017583537354611264343
   PubMed Web of Science ®Google Scholar
• RosatoPAnastasiadouEGargNDifferential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2Leukemia201226112343235222614176
   PubMed Web of Science ®Google Scholar
• PortisTLongneckerREpstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathwayOncogene200423538619862815361852
   PubMed Web of Science ®Google Scholar
• MancaoCHammerschmidtWEpstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survivalBlood2007110103715372117682125
   PubMed Web of Science ®Google Scholar
• Swanson-MungersonMACaldwellRGBultemaRLongneckerREpstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigenJ Virol200579127355736215919890
   PubMed Web of Science ®Google Scholar
• GiresOZimber-StroblUGonnellaRLatent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor moleculeEMBO J1997162061316140
   Web of Science ®Google Scholar
• WangDLiebowitzDKieffEAn EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cellsCell1985433 Pt 28318403000618
   PubMed Web of Science ®Google Scholar
• IzumiKMKieffEDThe Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaBProc Natl Acad Sci U S A1997942312592125979356494
   PubMed Web of Science ®Google Scholar
• RobertsMLCooperNRActivation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformationVirology1998240193999448693
   PubMed Web of Science ®Google Scholar
• EliopoulosAGYoungLSActivation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)Oncogene19981613173117429582021
   PubMed Web of Science ®Google Scholar
• DawsonCWTramountanisGEliopoulosAGYoungLSEpstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodelingJ Biol Chem200327863694370412446712
   PubMed Web of Science ®Google Scholar
• MainouBAEverlyDNJrRaab-TraubNEpstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3KOncogene200524466917692416007144
   PubMed Web of Science ®Google Scholar
• WangSRoweMLundgrenEExpression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell linesCancer Res19965620461046138840972
   PubMed Web of Science ®Google Scholar
• PegmanPMSmithSMD’SouzaBNEpstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathwayJ Virol200680168133814416873269
   PubMed Web of Science ®Google Scholar
• ClybouwCMcHichiBMouhamadSEBV infection of human B lymphocytes leads to down-regulation of Bim expression: relationship to resistance to apoptosisJ Immunol200517552968297316116183
   PubMed Web of Science ®Google Scholar
• AndertonEYeeJSmithPCrookTWhiteREAlldayMJTwo Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt’s lymphomaOncogene200827442143317653091
   PubMed Web of Science ®Google Scholar
• MaruoSZhaoBJohannsenEKieffEZouJTakadaKEpstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expressionProc Natl Acad Sci U S A201110851919192421245331
   PubMed Web of Science ®Google Scholar
• SahaAMurakamiMKumarPBajajBSimsKRobertsonESEpstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2J Virol20098394652466919244339
   PubMed Web of Science ®Google Scholar
• SatoYShirataNKudohAExpression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcriptionVirology2009388120421119375142
   PubMed Web of Science ®Google Scholar
• KashubaEYurchenkoMYenamandraSPEpstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53Int J Cancer2011128481782520473904
   PubMed Web of Science ®Google Scholar
• PokrovskajaKEhlin-HenrikssonBBartkovaJPhenotype-related differences in the expression of D-type cyclins in human B cell-derived linesCell Growth Differ1996712172317328959341
   PubMedGoogle Scholar
• MatarazaJMTumangJRGuminaMRGurdakSMRothsteinTLChilesTCDisruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient miceJ Immunol2006177278779516818732
   PubMed Web of Science ®Google Scholar
• BradyGMacarthurGJFarrellPJEpstein-Barr virus and Burkitt lymphomaPostgrad Med J20088499337237718716017
   PubMed Web of Science ®Google Scholar
• RickinsonABYoungLSRoweMInfluence of the Epstein-Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cellsJ Virol1987615131013173033261
   PubMed Web of Science ®Google Scholar
• LucchesiWBradyGDittrich-BreiholzOKrachtMRussRFarrellPJDifferential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2J Virol200882157456746618480445
   PubMed Web of Science ®Google Scholar
• AitkenCSenguptaSKAedesCMossDJSculleyTBHeterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virusJ Gen Virol199475Pt 1951008113744
   PubMed Web of Science ®Google Scholar